FDA approves ProHeart 12July 8, 2019The U.S. Food and Drug Administration’s (FDA’s) Center for Veterinary Medicine (CVM) has approved ProHeart 12 (moxidectin) extended release injectable suspension for dogs one year and older.
SPONSORED CONTENTNutrition to improve mobility in dogsNutrition that helps support joint cartilage preservation and is clinically proven to improve mobility in as little as 3 weeks. + Learn More